 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE-- DNA--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 2,802,272 shares of its common stock at a price to the public of 110.00 per share, which consists of 2,727,272 shares to be sold by Twist and 75,000 shares to be sold by certain selling stockholders. The gross proceeds of 